505016/Doctor Launch Fund of Xinxiang Medical University[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2022	1
2023	1
2024	2

Page 1

Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma.

Zhao T, Wei P, Zhang C, Zhou S, Liang L, Guo S, Yin Z, Cheng S, Gan Z, Xia Y, Zhang Y, Guo S, Zhong J, Yang Z, Tu F, Wang Q, Bai J, Ren F, Feng Z, Jia H. Zhao T, et al. Elife. 2024 Mar 5;12:RP90911. doi: 10.7554/eLife.90911. Elife. 2024. PMID: 38441416 Free PMC article.

Fluvoxamine prompts the antitumor immune effect via inhibiting the PD-L1 expression on mice-burdened colon tumor.

Wei P, Jia H, Li R, Zhang C, Guo S, Wei S, Sun K, Cheng S, Cui T, Huang J, Guo S, Guo J, Yang Z, Zhong J, Lu C, Feng Z, Zhao T. Wei P, et al. Cell Biol Int. 2023 Feb;47(2):439-450. doi: 10.1002/cbin.11936. Epub 2022 Oct 19. Cell Biol Int. 2023. PMID: 36259746

Maprotiline Prompts an Antitumour Effect by Inhibiting PD-L1 Expression in Mice with Melanoma.

Liang L, Li Y, Jiao Y, Zhang C, Shao M, Jiang H, Wu Z, Chen H, Guo J, Jia H, Zhao T. Liang L, et al. Curr Mol Pharmacol. 2024;17(1):e18761429259562. doi: 10.2174/0118761429259562230925055749. Curr Mol Pharmacol. 2024. PMID: 37982288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year